Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Primary Care

 

FREE BLOG HBI Awards 2018: Building a sub-brand to appeal to new consumers

When evaluating its patient base in the UAE in 2016, NMC found that the majority came from the Indian sub-continent and the general perception was that it was an Indian healthcare brand. To change this and to increase expat and Emirati patients, NMC introduced a new “Royal” brand of hospital, which focused on the preferences of expats and Emiratis for a personalised care service adding to the overall patient experience. The leading non-Royal brand NMC hospital has 45% of its patients from India, 2% Western expats and 8% UAE national. With the new Royal brand, this ratio was reversed with 45% UAE nationals, 10% Western Expats and 15% from India. Here is how.

Mehilainen sold to CVC

Mehilainen, the big Finnish occupational outpatient group has been sold in a deal valued at around €1.8bn to CVC by Triton and KKR. We talk to Mehilainen CEO Janne-Olli Järvenpää about the deal and growth plans. Will he look outside Finland?

Interview: Franz-Robert Klingan, Bain & Company

Healthcare Europa speaks to Franz-Robert Klingan, Munich-based partner at global consultants Bain & Company who runs its healthcare private equity practice for EMEA, to find out his three key messages from the last year and where he thinks the hotbeds of activity will be going forward.

Chinese health apps raise $1.6bn dollars – but are they what the doctor ordered?

Digital platforms in China are raising huge sums. In the last month, Tencent-backed WeDoctor raised $500m from investors in a private share sale that values the company at $5.5bn, while Ping An spinoff Good Doctor raised $1.1bn with a Hong Kong-exchange listed IPO. Healthcare Nova speaks to L.E.K.’s Shanghai-based managing director Stephen Sunderland to find out more about the digital health revolution.

SOTE vote pushes back Mehilainen sale

The sale or IPO of Finnish healthcare group Mehiläinen might come after the country's parliament votes on SOTE in June. We talk to an advisor about why waiting makes sense and which of the two exit options its private equity owners will opt for.

Interview: Franz-Robert Klingan, Bain & Company

Healthcare Europa speaks to Franz-Robert Klingan, Munich-based partner at global consultants Bain & Company who runs its healthcare private equity practice for EMEA, to find out his three key messages from the last year and where he thinks the hotbeds of activity will be going forward.

Brazilian IPOs show an improving market – but were they a success?

Brazilian Healthcare providers Notre Dame Intermédica and Hapvida have both just gone public. Healthcare Nova speaks to a Brazil-based healthcare expert who shares his thoughts on whether the IPOs were successful, and what this means for the wider Brazilian healthcare market.

Hope for tariffs in Portugal

Portuguese for-profit operators say they are optimistic that the leftist government will not introduce swingeing tariff cuts. 

Find Us